Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-28

Clinical Trial Update: 14729-D9831C00002- 1 Month Biopsy Study [Phase 2]

View source ↗

Summary

A Phase 2 COPD trial (1-month biopsy study) sponsored by AstraZeneca has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED | Results posted: 2014-02-28